Skip to main content
Sign In

University of Colorado College of Nursing

College of Nursing
 

Catherine M. Jankowski, PhD, FACSM

Associate Professor


Catherine Jankowski

Catherine.Jankowski@ucdenver.edu

Catherine (Kathy) Jankowski is an exercise physiologist who joined the faculty in 2012 after ten years of clinical research experience in the Division of Geriatric Medicine at the CU School of Medicine. The unifying theme of Jankowski’s research is the maintenance and promotion of physical function during aging, cancer survivorship and chronic disease. For example, she implements exercise and sex hormone interventions to study human musculoskeletal adaptations to overload and disuse. She has been the recipient of extramural funding from the National Institutes of Health and Centers for Disease Control in addition to intramural funding. Dr. Jankowski collaborates with faculty in Geriatric Medicine, Infectious Disease, Internal Medicine, Endocrinology, Physical Therapy, Public Health, and the CON. She is a fellow of the American College of Sports Medicine (ACSM) and is an ACSM Certified Clinical Exercise Specialist. She is an Associate Editor of the Yearbook of Sports Medicine and serves on the Exercise and Rehabilitation Advisory Council of the National Osteoporosis Foundation. Jankowski speaks to community groups about exercise for older adults and exercise during cancer survivorship.

Degree Awarding Institution Field of Study Graduation Date
PhD Texas Woman’s University
Denton, Texas
Kinesiology 1996
MS Southern Connecticut State University
New Haven, Connecticut
Physical Education 1990
BS University of Connecticut
Storrs, Connecticut
Nutritional Sciences 1979
Gavin KM, Kohrt WM, Seals DR, Jankowski CM, Stauffer B, Moreau KLM, (2012). Hysterectomy is associated with larger artery stiffening in estrogen-deficient postmenopausal women. Menopause 19(9).
Jankowski CM, Matthews EE, (2011).Exercise Guidelines for Adults with Cancer: A Vital Role in Survivorship. J Onc Nurs Soc, 15(6), 683-686.
Jankowski CM & Kohrt WM, (2011). Dehydroepiandrosterone Replacement and Bone Mineral Density, In: DHEA in Human Health and Aging, Boca Raton: Taylor and Francis Group, pp 113-121.
Villalon KL, Gozansky WS, Van Pelt RE, Wolfe P, Jankowski CM, Schwartz, RS, Kohrt WM, (2011). A losing battle: weight regain does not restore weight loss-induced bone loss in postmenopausal women. Obesity, 19 (12), 2345-2350. doi:10.1038/oby.2011.263.
Jankowski CM, Gozansky WS, Van Pelt RE, Wolfe P, Schwartz RS, Kohrt WM, (2011). Oral dehydroepiandrosterone (DHEA) replacement in older adults: effects on central adiposity, glucose metabolism, and blood lipids. Clin Endocrinol (Oxf). doi: 10.1111/j.1365-2265.2011.04073.x.
Van Pelt RE, Jankowski CM, Gozansky WS, Wolfe P, Schwartz RS, Kohrt WM, (2011). Sex differences in the association of thigh fat and metabolic risk in older adults. Obesity (Silver Spring), 19(2), 422-428.
Kohrt WM, Barry DW, Van Pelt, RE, Jankowski CM, Wolfe P, Schwartz RS, (2010). Timing of ibuprofen use and bone mineral adaptations to exercise training. JBMR, 25(6), 1415-1422.
Jankowski CM, Gozansky WS, Kittelson JM, Van Pelt RE, Schwartz RS, Kohrt WM, (2008). Increases in bone mineral density in response to oral dehydroepiandrosterone replacement in older adults appear to be mediated by serum estrogens. J Clin Endocrinol Metab, 4767-4773. PMC2626446
Jankowski  CM, Gozansky WS, Van Pelt RE, Schenkman ML, Wolfe P, Schwartz RS, Kohrt WM, (2008).  Relative contributions of adiposity and muscularity to physical function in healthy older adults. Obesity, 16(5), 1039-44.
Jankowski CM, Gozansky WS, Schwartz RS, Dahl DJ, Kittelson JM, Scott SM, Van Pelt RE, Kohrt, WM. (2006). Effects of DHEA replacement therapy on bone mineral density in older adults: a randomized, controlled trial. J Clin Endocrinol Metab, 91(8), 2986-2993.
Van Pelt RE, Jankowski CM, Gozansky WS, Kohrt WM, (2005). Lower-body adiposity and metabolic disease protection in postmenopausal women. J Clin Endocrinol Metab, 90, 4573-4578. PMC2819700
Gozansky WS, Kohrt WM, Van Pelt RE, Jankowski CM, Schwartz RS, (2005). Protection of bone mass by estrogens and raloxifene during exercise-induced weight loss. J Clin Endocrinol Metab, 90(1), 52-59.
Jankowski CM, Sonko B, Gozansky WS, Kohrt WM, (2004). Deuterium dilution: the time course of 2H enrichment in saliva, urine, and serum. Clinical Chemistry, 50(9), 1699-1701.
Jankowski CM, Ben-Ezra V, Gozansky WS, Scheaffer, SE, (2004). Effects of oral contraceptives on glucoregulatory responses to exercise. Metabolism, 53, 348-352.
Kohrt WM & Jankowski CM, (2004). Biomarkers to Predict the Occurrence of Bone Stress and Matrix Abnormalities Due to Sustained and Intensive Physical Activity, In: Monitoring Metabolic Status: Predicting Decrements in Physiological and Cognitive Performance, Institute of Medicine, Washington DC: National Academy Press, pp.356-363.
Slininger D, Sherrill C, Jankowski CM, (2000). Children’s attitudes toward peers with severe disabilities: revisiting Contact Theory. Adapted Physical Activity Quarterly, 17, 176-196.
Jankowski CM, Kendrick K, Morriss R, Nichols D, Ben-Ezra V, (1999). Effect of exercise on postprandial insulin responses in Mexican American and non-Hispanic women. Metabolism, 48, 971-977.
Ben-Ezra V, Jankowski CM, Kendrick K, Nichols D, (1995). The effect of intensity and energy expenditure on post exercise insulin responses in women. J Appl Physiol, 79, 2029-2034.
Sanborn C & Jankowski CM, (1994). Physiologic considerations for women in sport. Clinics in Sports Medicine. Philadelphia: W.B. Saunders & Co., 315-327.
Sanborn C & Jankowski CM, (1994). Gender specific physiology. Medical and Orthopedic Issues of Active and Athletic Women. Philadelphia: Hanley & Belfus, Inc., 23-28.
Sanborn C & Jankowski CM, (1994). Exercise and the female athlete. Current Therapy in Sports Medicine. 3 ed. St. Louis: Mosby, 546-549.
Title Organization Year
Fellow American College of Sports Medicine

2009

  • 2012, Co-Investigator/Gerontologist, Inflammation and Functional Capacity: Trajectory of those Aging with HIV-Infection, ACTG A5323, $200,000
  • 2009, Co-Investigator, Cancer Prevention and Control Research Network (CPCRN) Site, Cancer Survivorship, NCI/CDC $270,0002006, PI, Acetaminophen and Impaired Musculoskeletal Adaptations to Exercise Training, NIA, completed
  • 2006, Co-I, COX Inhibition & Musculoskeletal Responses to Exercise, NIA, $363,912
  • 2000, Co-I, Biological Effects of DHEA in the Elderly, NIA, completed
  • Position statement on Exercise on Bone Health, Exercise and Rehabilitation Advisory Council of the National Osteoporosis Foundation, 2012
  • What is Next (WIN) Wellness Program for Cancer Survivors, 2011, funded
  • Exercise Recommendations for Cancer Survivors: Development of Educational Materials, 2010, unfunded